CCND2 and CCND3 hijack immunoglobulin light chain enhancers in cyclin D1-negative mantle cell lymphoma

Mantle cell lymphoma (MCL) is characterized by the t(11;14)(q13;q32) translocation resulting in overexpression of cyclin D1. However, a small subset of cyclin D1− MCL has been recognized, and approximately one-half of them harbor CCND2 translocations while the primary event in cyclin D1−/D2− MCL rem...

Full description

Bibliographic Details
Authors: Martín García, David, Navarro López, Alba, Valdés Mas, Rafael, Clot Razquin, Guillem, Gutiérrez-Abril, Jesús, Prieto, Miriam, Ribera Cortada, Inmaculada, Woroniecka, Renata, Rymkiewicz, Grzegorz, Bens, Susanne, Leval, Laurence de, Rosenwald, Andreas, Ferry, Judith A., Hsi, Eric D., Fu, Kai, Delabie, Jan, Weisenburger, Dennis D., Jong, Daphne de, Climent, Fina, O'Connor, Sheila J., Swerdlow, Steven H., Torrents Arenales, David, Beltran i Agulló, Sergi, Espinet Solà, Blanca, González Farré, Blanca, Veloza, Luis, Costa, Dolors, Matutes, Estella, Siebert, Reiner, Ott, German, Quintanilla Martinez, Leticia, Jaffe, Elaine S., López-Otin, Carlos, Salaverria Frigola, Itziar, Puente, Xose S., Campo Güerri, Elias, Beà Bobet, Sílvia M.
Format: article
Status:Versión aceptada para publicación
Publication Date:2019
Country:España
Institution:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repository:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:2445/147397
Online Access:https://hdl.handle.net/2445/147397
Access Level:Open access
Keyword:Limfomes
Carcinogènesi
Pronòstic mèdic
Lymphomas
Carcinogenesis
Prognosis
id ES_4aa3ddb0e92508e69eba9e321d838cc5
oai_identifier_str oai:recercat.cat:2445/147397
network_acronym_str ES
network_name_str España
repository_id_str
spelling CCND2 and CCND3 hijack immunoglobulin light chain enhancers in cyclin D1-negative mantle cell lymphomaMartín García, DavidNavarro López, AlbaValdés Mas, RafaelClot Razquin, GuillemGutiérrez-Abril, JesúsPrieto, MiriamRibera Cortada, InmaculadaWoroniecka, RenataRymkiewicz, GrzegorzBens, SusanneLeval, Laurence deRosenwald, AndreasFerry, Judith A.Hsi, Eric D.Fu, KaiDelabie, JanWeisenburger, Dennis D.Jong, Daphne deCliment, FinaO'Connor, Sheila J.Swerdlow, Steven H.Torrents Arenales, DavidBeltran i Agulló, SergiEspinet Solà, BlancaGonzález Farré, BlancaVeloza, LuisCosta, DolorsMatutes, EstellaSiebert, ReinerOtt, GermanQuintanilla Martinez, LeticiaJaffe, Elaine S.López-Otin, CarlosSalaverria Frigola, ItziarPuente, Xose S.Campo Güerri, EliasBeà Bobet, Sílvia M.LimfomesCarcinogènesiPronòstic mèdicLymphomasCarcinogenesisPrognosisMantle cell lymphoma (MCL) is characterized by the t(11;14)(q13;q32) translocation resulting in overexpression of cyclin D1. However, a small subset of cyclin D1− MCL has been recognized, and approximately one-half of them harbor CCND2 translocations while the primary event in cyclin D1−/D2− MCL remains elusive. To identify other potential mechanisms driving MCL pathogenesis, we investigated 56 cyclin D1−/SOX11+ MCL by fluorescence in situ hybridization (FISH), whole-genome/exome sequencing, and gene-expression and copy-number arrays. FISH with break-apart probes identified CCND2 rearrangements in 39 cases (70%) but not CCND3 rearrangements. We analyzed 3 of these negative cases by whole-genome/exome sequencing and identified IGK (n = 2) and IGL (n = 1) enhancer hijackings near CCND3 that were associated with cyclin D3 overexpression. By specific FISH probes, including the IGK enhancer region, we detected 10 additional cryptic IGK juxtapositions to CCND3 (6 cases) and CCND2 (4 cases) in MCL that overexpressed, respectively, these cyclins. A minor subset of 4 cyclin D1− MCL cases lacked cyclin D rearrangements and showed upregulation of CCNE1 and CCNE2. These cases had blastoid morphology, high genomic complexity, and CDKN2A and RB1 deletions. Both genomic and gene-expression profiles of cyclin D1− MCL cases were indistinguishable from cyclin D1+ MCL. In conclusion, virtually all cyclin D1− MCLs carry CCND2/CCND3 rearrangements with immunoglobulin genes, including a novel IGK/L enhancer hijacking mechanism. A subset of cyclin D1−/D2−/D3− MCL with aggressive features has cyclin E dysregulation. Specific FISH probes may allow the molecular identification and diagnosis of cyclin D1− MCL.American Society of Hematology2020202020192020info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersion30 p.application/pdfhttps://hdl.handle.net/2445/147397Articles publicats en revistes (Fonaments Clínics)reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)InglésVersió postprint del document publicat a: https://doi.org/10.1182/blood-2018-07-862151Blood, 2019, vol. 133, num. 9, p. 940-951https://doi.org/10.1182/blood-2018-07-862151(c) American Society of Hematology, 2018info:eu-repo/semantics/openAccessoai:recercat.cat:2445/1473972026-05-29T05:05:01Z
dc.title.none.fl_str_mv CCND2 and CCND3 hijack immunoglobulin light chain enhancers in cyclin D1-negative mantle cell lymphoma
title CCND2 and CCND3 hijack immunoglobulin light chain enhancers in cyclin D1-negative mantle cell lymphoma
spellingShingle CCND2 and CCND3 hijack immunoglobulin light chain enhancers in cyclin D1-negative mantle cell lymphoma
Martín García, David
Limfomes
Carcinogènesi
Pronòstic mèdic
Lymphomas
Carcinogenesis
Prognosis
title_short CCND2 and CCND3 hijack immunoglobulin light chain enhancers in cyclin D1-negative mantle cell lymphoma
title_full CCND2 and CCND3 hijack immunoglobulin light chain enhancers in cyclin D1-negative mantle cell lymphoma
title_fullStr CCND2 and CCND3 hijack immunoglobulin light chain enhancers in cyclin D1-negative mantle cell lymphoma
title_full_unstemmed CCND2 and CCND3 hijack immunoglobulin light chain enhancers in cyclin D1-negative mantle cell lymphoma
title_sort CCND2 and CCND3 hijack immunoglobulin light chain enhancers in cyclin D1-negative mantle cell lymphoma
dc.creator.none.fl_str_mv Martín García, David
Navarro López, Alba
Valdés Mas, Rafael
Clot Razquin, Guillem
Gutiérrez-Abril, Jesús
Prieto, Miriam
Ribera Cortada, Inmaculada
Woroniecka, Renata
Rymkiewicz, Grzegorz
Bens, Susanne
Leval, Laurence de
Rosenwald, Andreas
Ferry, Judith A.
Hsi, Eric D.
Fu, Kai
Delabie, Jan
Weisenburger, Dennis D.
Jong, Daphne de
Climent, Fina
O'Connor, Sheila J.
Swerdlow, Steven H.
Torrents Arenales, David
Beltran i Agulló, Sergi
Espinet Solà, Blanca
González Farré, Blanca
Veloza, Luis
Costa, Dolors
Matutes, Estella
Siebert, Reiner
Ott, German
Quintanilla Martinez, Leticia
Jaffe, Elaine S.
López-Otin, Carlos
Salaverria Frigola, Itziar
Puente, Xose S.
Campo Güerri, Elias
Beà Bobet, Sílvia M.
author Martín García, David
author_facet Martín García, David
Navarro López, Alba
Valdés Mas, Rafael
Clot Razquin, Guillem
Gutiérrez-Abril, Jesús
Prieto, Miriam
Ribera Cortada, Inmaculada
Woroniecka, Renata
Rymkiewicz, Grzegorz
Bens, Susanne
Leval, Laurence de
Rosenwald, Andreas
Ferry, Judith A.
Hsi, Eric D.
Fu, Kai
Delabie, Jan
Weisenburger, Dennis D.
Jong, Daphne de
Climent, Fina
O'Connor, Sheila J.
Swerdlow, Steven H.
Torrents Arenales, David
Beltran i Agulló, Sergi
Espinet Solà, Blanca
González Farré, Blanca
Veloza, Luis
Costa, Dolors
Matutes, Estella
Siebert, Reiner
Ott, German
Quintanilla Martinez, Leticia
Jaffe, Elaine S.
López-Otin, Carlos
Salaverria Frigola, Itziar
Puente, Xose S.
Campo Güerri, Elias
Beà Bobet, Sílvia M.
author_role author
author2 Navarro López, Alba
Valdés Mas, Rafael
Clot Razquin, Guillem
Gutiérrez-Abril, Jesús
Prieto, Miriam
Ribera Cortada, Inmaculada
Woroniecka, Renata
Rymkiewicz, Grzegorz
Bens, Susanne
Leval, Laurence de
Rosenwald, Andreas
Ferry, Judith A.
Hsi, Eric D.
Fu, Kai
Delabie, Jan
Weisenburger, Dennis D.
Jong, Daphne de
Climent, Fina
O'Connor, Sheila J.
Swerdlow, Steven H.
Torrents Arenales, David
Beltran i Agulló, Sergi
Espinet Solà, Blanca
González Farré, Blanca
Veloza, Luis
Costa, Dolors
Matutes, Estella
Siebert, Reiner
Ott, German
Quintanilla Martinez, Leticia
Jaffe, Elaine S.
López-Otin, Carlos
Salaverria Frigola, Itziar
Puente, Xose S.
Campo Güerri, Elias
Beà Bobet, Sílvia M.
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Limfomes
Carcinogènesi
Pronòstic mèdic
Lymphomas
Carcinogenesis
Prognosis
topic Limfomes
Carcinogènesi
Pronòstic mèdic
Lymphomas
Carcinogenesis
Prognosis
description Mantle cell lymphoma (MCL) is characterized by the t(11;14)(q13;q32) translocation resulting in overexpression of cyclin D1. However, a small subset of cyclin D1− MCL has been recognized, and approximately one-half of them harbor CCND2 translocations while the primary event in cyclin D1−/D2− MCL remains elusive. To identify other potential mechanisms driving MCL pathogenesis, we investigated 56 cyclin D1−/SOX11+ MCL by fluorescence in situ hybridization (FISH), whole-genome/exome sequencing, and gene-expression and copy-number arrays. FISH with break-apart probes identified CCND2 rearrangements in 39 cases (70%) but not CCND3 rearrangements. We analyzed 3 of these negative cases by whole-genome/exome sequencing and identified IGK (n = 2) and IGL (n = 1) enhancer hijackings near CCND3 that were associated with cyclin D3 overexpression. By specific FISH probes, including the IGK enhancer region, we detected 10 additional cryptic IGK juxtapositions to CCND3 (6 cases) and CCND2 (4 cases) in MCL that overexpressed, respectively, these cyclins. A minor subset of 4 cyclin D1− MCL cases lacked cyclin D rearrangements and showed upregulation of CCNE1 and CCNE2. These cases had blastoid morphology, high genomic complexity, and CDKN2A and RB1 deletions. Both genomic and gene-expression profiles of cyclin D1− MCL cases were indistinguishable from cyclin D1+ MCL. In conclusion, virtually all cyclin D1− MCLs carry CCND2/CCND3 rearrangements with immunoglobulin genes, including a novel IGK/L enhancer hijacking mechanism. A subset of cyclin D1−/D2−/D3− MCL with aggressive features has cyclin E dysregulation. Specific FISH probes may allow the molecular identification and diagnosis of cyclin D1− MCL.
publishDate 2019
dc.date.none.fl_str_mv 2019
2020
2020
2020
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/147397
url https://hdl.handle.net/2445/147397
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Versió postprint del document publicat a: https://doi.org/10.1182/blood-2018-07-862151
Blood, 2019, vol. 133, num. 9, p. 940-951
https://doi.org/10.1182/blood-2018-07-862151
dc.rights.none.fl_str_mv (c) American Society of Hematology, 2018
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) American Society of Hematology, 2018
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 30 p.
application/pdf
dc.publisher.none.fl_str_mv American Society of Hematology
publisher.none.fl_str_mv American Society of Hematology
dc.source.none.fl_str_mv Articles publicats en revistes (Fonaments Clínics)
reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869407507207684096
score 15,812429